{"parse":{"title":"Medical Research Council Technology","pageid":34773867,"revid":830364107,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox vcard\" style=\"width:22em\"><caption class=\"fn org\">LifeArc (the new name for Medical Research Council Technology)</caption><tbody><tr><th scope=\"row\" style=\"padding-right:0.5em;\">Industry</th><td class=\"category\" style=\"line-height:1.35em;\">\n<a href=\"/wiki/Medical_research\" title=\"Medical research\">Life science medical research</a> charity</td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\">Founded</th><td style=\"line-height:1.35em;\">\n2000</td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\">Headquarters</th><td class=\"adr\" style=\"line-height:1.35em;\">\n<span class=\"locality\"><a href=\"/wiki/London\" title=\"London\">London</a></span>, <span class=\"country-name\"><a href=\"/wiki/UK\" class=\"mw-redirect\" title=\"UK\">UK</a></span></td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Number of locations</div></th><td style=\"line-height:1.35em;\">\n<a href=\"/wiki/London\" title=\"London\">London</a>, Stevenage, <a href=\"/wiki/Edinburgh\" title=\"Edinburgh\">Edinburgh</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Key people</div></th><td class=\"agent\" style=\"line-height:1.35em;\">\nCEO: Dave Tapolczay, Executive Director Diagnostics &amp; Science Foresight: Michael Dalrymple, Executive Director Technology Transfer and Business Development: Andrew Farquharson, Executive Director Drug Discovery: Justin Bryans, Chief Financial Officer: Andrew Mercieca, General Counsel &amp; Company Secretary: Edward Bliss, Executive Director Human Resources: Amanda Cowley</td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\">Services</th><td class=\"category\" style=\"line-height:1.35em;\">\nIP management, drug discovery, diagnostics development, antibody engineering, charity portfolio review</td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Number of employees</div></th><td style=\"line-height:1.35em;\">\n180</td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\">Website</th><td style=\"line-height:1.35em;\">\n<span class=\"url\"><a rel=\"nofollow\" class=\"external text\" href=\"http://lifearc.org\">lifearc<wbr />.org</a></span></td></tr></tbody></table>\n<p><b>LifeArc, the new name for Medical Research Council Technology (MRC Technology, MRCT)</b> is a British <a href=\"/wiki/Medical_research\" title=\"Medical research\">life science medical research</a> charity. It was established in 2000 to <a href=\"/wiki/Translational_research\" title=\"Translational research\">translate</a> the work of <a href=\"/wiki/Medical_Research_Council_(UK)\" class=\"mw-redirect\" title=\"Medical Research Council (UK)\">UK Medical Research Council</a> research scientists.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\n</p><p>Today LifeArc provides <a href=\"/wiki/Intellectual_property\" title=\"Intellectual property\">intellectual property</a> identification, protection and commercialisation, technology development, early stage <a href=\"/wiki/Drug_discovery\" title=\"Drug discovery\">drug discovery</a> and <a href=\"/wiki/Humanized_antibody\" title=\"Humanized antibody\">antibody humanization</a> services for the MRC, academia, biotechnology and pharmaceutical organisations and charities, aiming to move promising medical research forward into viable and accessible patient treatments. <sup id=\"cite_ref-Researcharticle_2-0\" class=\"reference\"><a href=\"#cite_note-Researcharticle-2\">&#91;2&#93;</a></sup> Profits from LifeArc's activities are reinvested into further research. \n</p><p><br />\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Activities\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Activities</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Key_achievements\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Key achievements</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medical_Research_Council_Technology&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>MRC Technology started as the Medical Research Council Liaison Office in 1984, and in 1986 the MRC Collaborative Centre, a laboratory-based technology transfer function, was founded. In 1993, the Liaison Office became MRC's Technology Transfer Group, responsible for office based patenting and licensing.\n</p><p>MRC Technology was set up as a charity and a company limited by guarantee in 2000 to incorporate patenting, licensing and research functions.<sup id=\"cite_ref-MRCTrole_3-0\" class=\"reference\"><a href=\"#cite_note-MRCTrole-3\">&#91;3&#93;</a></sup>\n</p><p>On <a rel=\"nofollow\" class=\"external text\" href=\"https://www.lifearc.org/lifearc-set-transform-medical-research-landscape/\">15 June 2017</a> it  officially became LifeArc.\n</p>\n<h2><span class=\"mw-headline\" id=\"Activities\">Activities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medical_Research_Council_Technology&amp;action=edit&amp;section=2\" title=\"Edit section: Activities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>LifeArc has humanised a number of antibodies on behalf of other organisations. Four of these, <a href=\"/wiki/Natalizumab\" title=\"Natalizumab\">Tysabri (Biogen Idec/Elan)</a>, <a href=\"/wiki/Tocilizumab\" title=\"Tocilizumab\">Actemra (Hoffmann-La Roche/Chugai)</a>, <a href=\"/wiki/Vedolizumab\" title=\"Vedolizumab\">Entyvio (Millenium Pharma/Takeda)</a> and <a href=\"/wiki/Pembrolizumab\" title=\"Pembrolizumab\">Keytruda (Merck/MSD)</a>, are now on the market.<sup id=\"cite_ref-MRCLMB_4-0\" class=\"reference\"><a href=\"#cite_note-MRCLMB-4\">&#91;4&#93;</a></sup>\n</p><p>In 2010, LifeArc signed a deal with the drug company <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a> to share chemical compounds to help identify potential treatments for serious diseases.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-MRCTAZ_6-0\" class=\"reference\"><a href=\"#cite_note-MRCTAZ-6\">&#91;6&#93;</a></sup>\n</p><p>LifeArc is a member of a Global Drug Discovery Alliance along with <a href=\"/wiki/Centre_for_Drug_Research_and_Development\" title=\"Centre for Drug Research and Development\">the Centre for Drug Research and Development</a>, <a href=\"/wiki/Scripps_Research_Institute\" title=\"Scripps Research Institute\">the Scripps Research Institute</a>, Cancer Research Technology, the Lead Discovery Centre and the Centre for Drug Design and Discovery, dedicated to translating health research into new medicines and working together to improve the conversion of global early-stage research into much-needed new therapies.<sup id=\"cite_ref-SciBX_7-0\" class=\"reference\"><a href=\"#cite_note-SciBX-7\">&#91;7&#93;</a></sup>\n</p><p><a rel=\"nofollow\" class=\"external text\" href=\"http://www.dementiaconsortium.org/\">Dementia Consortium</a> was launched in December 2013 - a unique \u00a33m drug discovery collaboration between <a rel=\"nofollow\" class=\"external text\" href=\"http://www.alzheimersresearchuk.org/\">Alzheimer's Research UK</a>, LifeArc and pharmaceutical companies <a rel=\"nofollow\" class=\"external text\" href=\"http://www.eisai.com/\">Eisai</a> and <a rel=\"nofollow\" class=\"external text\" href=\"http://www.lilly.co.uk/en/index.aspx\">Lilly</a>.\n</p><p><a rel=\"nofollow\" class=\"external text\" href=\"http://www.medicinesaccelerationprogram.org/\">Neurodegeneration Medicines Acceleration Programme</a> was established in November 2014 to revive promising drugs for brain diseases, which have stalled for non-scientific reasons. \n</p>\n<h2><span class=\"mw-headline\" id=\"Key_achievements\">Key achievements</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medical_Research_Council_Technology&amp;action=edit&amp;section=3\" title=\"Edit section: Key achievements\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"plainlist\"><ul><li>Over 400 commercial licences signed</li><li>Helped launch 12 drugs on the market</li><li>Helped form 18 start ups</li><li>Generated over \u00a3600 million in revenues for the <a href=\"/wiki/Medical_Research_Council_(United_Kingdom)\" title=\"Medical Research Council (United Kingdom)\">MRC</a></li><li>Humanized two antibodies now on the market</li><li>Humanized six antibodies currently in clinical trials</li></ul></div>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medical_Research_Council_Technology&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\">Paul Feldman, Corinna Lotz, <i>A world to win: a rough guide to a future without global capitalism</i>, 2004, Lupus Books, <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0952345412\" title=\"Special:BookSources/0952345412\">0952345412</a>, 9780952345411</span>\n</li>\n<li id=\"cite_note-Researcharticle-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Researcharticle_2-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.research-europe.com/index.php/2011/08/dave-tapolczay-ceo-of-medical-research-council-technology/\">\"CEO of MRC Technology\"</a>. Research Europe<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-01-03</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CEO+of+MRC+Technology&amp;rft.pub=Research+Europe&amp;rft_id=http%3A%2F%2Fwww.research-europe.com%2Findex.php%2F2011%2F08%2Fdave-tapolczay-ceo-of-medical-research-council-technology%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedical+Research+Council+Technology\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MRCTrole-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-MRCTrole_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Sir David Cooksey (2006-01-12). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.official-documents.gov.uk/document/other/0118404881/0118404881.pdf\">\"A Review of UK Health Funding\"</a> <span style=\"font-size:85%;\">(PDF)</span>. The Stationery Office. p.&#160;20.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Review+of+UK+Health+Funding&amp;rft.pages=20&amp;rft.pub=The+Stationery+Office&amp;rft.date=2006-01-12&amp;rft.au=Sir+David+Cooksey&amp;rft_id=http%3A%2F%2Fwww.official-documents.gov.uk%2Fdocument%2Fother%2F0118404881%2F0118404881.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedical+Research+Council+Technology\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MRCLMB-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-MRCLMB_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www2.mrc-lmb.cam.ac.uk/achievements/therapeutic-antibodies\">\"Therapeutic Antibodies and the LMB\"</a>. MRC Laboratory of Molecular Biology<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-02-17</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Therapeutic+Antibodies+and+the+LMB&amp;rft.pub=MRC+Laboratory+of+Molecular+Biology&amp;rft_id=http%3A%2F%2Fwww2.mrc-lmb.cam.ac.uk%2Fachievements%2Ftherapeutic-antibodies&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedical+Research+Council+Technology\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since January 2018\">permanent dead link</span></a></i>&#93;</span></sup></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\">Mark Wigglesworth, Terry Wood, eds, <i>Management of Chemical and Biological Samples for Screening Applications</i>, 2012, John Wiley &amp; Sons, <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/3527645276\" title=\"Special:BookSources/3527645276\">3527645276</a>, 9783527645275, <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=Hd6HRB4AWf8C&amp;pg=PA390&amp;dq\">google books</a></span>\n</li>\n<li id=\"cite_note-MRCTAZ-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-MRCTAZ_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.astrazeneca.com/Media/Press-releases/Article/AstraZeneca-and-MRC-Technology-Form-Strategic-Alliance\">\"AstraZeneca and MRC Technology Form Strategic Alliance in Discovery Research, Utilising Shared Compound Libraries\"</a>. AstraZeneca<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2013-01-03</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=AstraZeneca+and+MRC+Technology+Form+Strategic+Alliance+in+Discovery+Research%2C+Utilising+Shared+Compound+Libraries&amp;rft.pub=AstraZeneca&amp;rft_id=http%3A%2F%2Fwww.astrazeneca.com%2FMedia%2FPress-releases%2FArticle%2FAstraZeneca-and-MRC-Technology-Form-Strategic-Alliance&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedical+Research+Council+Technology\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-SciBX-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-SciBX_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Edelson, Steve (2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nature.com/scibx/journal/v6/n4/full/scibx.2013.78.html\">\"Translational Globetrotting\"</a>. <i>SciBX (Science-Business Exchange)</i>. <b>6</b> (4). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/scibx.2013.78\">10.1038/scibx.2013.78</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=SciBX+%28Science-Business+Exchange%29&amp;rft.atitle=Translational+Globetrotting&amp;rft.volume=6&amp;rft.issue=4&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1038%2Fscibx.2013.78&amp;rft.au=Edelson%2C+Steve&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fscibx%2Fjournal%2Fv6%2Fn4%2Ffull%2Fscibx.2013.78.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedical+Research+Council+Technology\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medical_Research_Council_Technology&amp;action=edit&amp;section=5\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.lifearc.org/\">LifeArc's website</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1270\nCached time: 20180909000032\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.200 seconds\nReal time usage: 0.270 seconds\nPreprocessor visited node count: 1430/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 19705/2097152 bytes\nTemplate argument size: 2487/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 6845/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.077/10.000 seconds\nLua memory usage: 3.15 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  248.236      1 -total\n 57.02%  141.549      1 Template:Reflist\n 37.58%   93.287      1 Template:Infobox_company\n 30.53%   75.788      1 Template:Infobox\n 20.87%   51.812      4 Template:Cite_web\n 14.53%   36.063      2 Template:ISBN\n 13.09%   32.496      1 Template:Dead_link\n 10.76%   26.701      1 Template:Fix\n  9.27%   23.023      2 Template:Category_handler\n  6.50%   16.131      2 Template:Catalog_lookup_link\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:34773867-0!canonical and timestamp 20180909000032 and revision id 830364107\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_January_2018"},{"sortkey":"","hidden":"","*":"Articles_with_permanently_dead_external_links"},{"sortkey":"","*":"Technology_transfer"},{"sortkey":"","*":"Companies_based_in_London"},{"sortkey":"","*":"Medical_research_institutes_in_the_United_Kingdom"},{"sortkey":"","*":"Charities_based_in_London"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with dead external links from January 2018"},{"ns":0,"exists":"","*":"AstraZeneca"},{"ns":0,"exists":"","*":"Centre for Drug Research and Development"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Drug discovery"},{"ns":0,"exists":"","*":"Edinburgh"},{"ns":0,"exists":"","*":"Humanized antibody"},{"ns":0,"exists":"","*":"Intellectual property"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"London"},{"ns":0,"exists":"","*":"Medical Research Council (UK)"},{"ns":0,"exists":"","*":"Medical Research Council (United Kingdom)"},{"ns":0,"exists":"","*":"Medical research"},{"ns":0,"exists":"","*":"Natalizumab"},{"ns":0,"exists":"","*":"Pembrolizumab"},{"ns":0,"exists":"","*":"Scripps Research Institute"},{"ns":0,"exists":"","*":"Tocilizumab"},{"ns":0,"exists":"","*":"Translational research"},{"ns":0,"exists":"","*":"UK"},{"ns":0,"exists":"","*":"Vedolizumab"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox company"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Br separated entries"},{"ns":10,"exists":"","*":"Template:Comma separated entries"},{"ns":10,"exists":"","*":"Template:Longitem"},{"ns":10,"exists":"","*":"Template:URL"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:ISBN"},{"ns":10,"exists":"","*":"Template:Catalog lookup link"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Yesno-no"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Error-small"},{"ns":10,"exists":"","*":"Template:Tl"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:Separated entries"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:URL"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:Check isxn"},{"ns":828,"exists":"","*":"Module:Error"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"}],"images":[],"externallinks":["http://www.research-europe.com/index.php/2011/08/dave-tapolczay-ceo-of-medical-research-council-technology/","http://www.official-documents.gov.uk/document/other/0118404881/0118404881.pdf","http://www2.mrc-lmb.cam.ac.uk/achievements/therapeutic-antibodies","https://books.google.com/books?id=Hd6HRB4AWf8C&pg=PA390&dq","http://www.astrazeneca.com/Media/Press-releases/Article/AstraZeneca-and-MRC-Technology-Form-Strategic-Alliance","http://www.nature.com/scibx/journal/v6/n4/full/scibx.2013.78.html","//doi.org/10.1038/scibx.2013.78","http://lifearc.org","https://www.lifearc.org/lifearc-set-transform-medical-research-landscape/","http://www.dementiaconsortium.org/","http://www.alzheimersresearchuk.org/","http://www.eisai.com/","http://www.lilly.co.uk/en/index.aspx","http://www.medicinesaccelerationprogram.org/","https://www.lifearc.org/"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"Medical_Research_Council_Technology","byteoffset":3206,"anchor":"History"},{"toclevel":1,"level":"2","line":"Activities","number":"2","index":"2","fromtitle":"Medical_Research_Council_Technology","byteoffset":4038,"anchor":"Activities"},{"toclevel":1,"level":"2","line":"Key achievements","number":"3","index":"3","fromtitle":"Medical_Research_Council_Technology","byteoffset":6706,"anchor":"Key_achievements"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"Medical_Research_Council_Technology","byteoffset":7057,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"5","fromtitle":"Medical_Research_Council_Technology","byteoffset":7087,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Medical Research Council Technology","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q16997514"}]}}